Results 201 to 210 of about 27,437,097 (250)

IS LESS THAN MASTECTOMY A SAFE OPTION?

Australian and New Zealand Journal of Surgery, 1982
Studies of the curability of breast cancer are reviewed. Of patients presenting with early disease, who are treated by ablative surgery, with or without postoperative radiotherapy, the proportion cured is small, with estimates of that proportion ranging from 0–30%. This fact must seriously modify arguments that failure to carry out a particular form of
A O, Langlands, K W, Tiver
openaire   +2 more sources

Therapeutic Options for Chronic Hepatitis B: Considerations and Controversies

The American Journal of Gastroenterology, 2006
Five agents are currently approved for the treatment of chronic hepatitis B infection. This article will discuss the three agents for which the most extensive data are available; interferon (IFN), lamivudine, and adefovir, while the following article by Dr.
openaire   +2 more sources

Telbivudine: a new option for the treatment of chronic hepatitis B

Expert Opinion on Biological Therapy, 2007
Chronic hepatitis B virus (HBV) infection affects > 350 million individuals worldwide. Chronic hepatitis B is associated with complications of end-stage liver disease, including cirrhosis and hepatocellular carcinoma. HBV replication is the best predictor of liver disease progression to cancer, and antiviral therapy may diminish or halt this ...
Andrés, Ruiz-Sancho, Julie, Sheldon, Vincent, Soriano   +2 more
openaire   +2 more sources

Levels of option B+ ART drugs adherence and associated factors among pregnant women following ART services at public health facilities of East Shawa Zone, Oromia, Ethiopia.

Sexual & Reproductive HealthCare, 2019
BACKGROUND Anti-retroviral therapy has led to a significant reduction in morbidity and mortality related to HIV/AIDS. However, this cannot be fully realized without addressing the barriers related to retention in care and medication adherence.
Mihretu Tarekegn, A. Baru, A. Seme
semanticscholar   +1 more source

Current options for the treatment ofHelicobacter pylori

Expert Opinion on Pharmacotherapy, 2013
Treatment of Helicobacter pylori (H. pylori) infection is crucial for prevalent disease's management, including gastritis, peptic ulcer and gastric cancer, whereas novel extradigestive causal associations are increasingly being recognized. Despite long-standing efforts, there is not as yet an optimal empirical therapy to eradicate H.
Sotirios D, Georgopoulos, Vasilios, Papastergiou, Stylianos, Karatapanis   +2 more
openaire   +2 more sources

Management options for intraparotid facial nerve schwannoma

Acta Oto-Laryngologica, 2012
Limited intraparotid facial nerve schwannoma (IFNS) and IFNS with intratemporal involvement should be managed separately because of their different characteristics. Limited IFNS with House-Brackman (HB) grade ≤ II should undergo tumor removal only if it can be resected easily off the nerve. For IFNS with intratemporal involvement and a HB grade ≤ II, a
Yang, Li, Hong, Jiang, Xingming, Chen, Haiyan, Wu, Guodong, Feng, Yang, Cha, Xiuyong, Ding, Zhiqiang, Gao   +7 more
openaire   +2 more sources

IDEAS AND OPTIONS IN ENGLISH FOR SPECIFIC PURPOSES

Studies in Second Language Acquisition, 2008
IDEAS AND OPTIONS IN ENGLISH FOR SPECIFIC PURPOSES.Helen Basturkmen. Mahwah, NJ: Erlbaum, 2006. Pp. xi + 186. $19.95 paper. Various approaches to teaching English for specific purposes (ESP) are examined in this volume, with a view toward encouraging readers to take a critical stance. The work aims to fill a gap in the existing ESP literature, which
openaire   +1 more source

Chronic Hepatitis B: Current and Future Treatment Options

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
Hepatitis B, a major viral infection that can lead to cirrhosis and hepatocellular carcinoma, is the ninth most common cause of death worldwide. Prevention of hepatitis B virus transmission is key to reducing the spread of this serious condition. Management of chronic hepatitis B requires significant knowledge of approved pharmacotherapeutic agents and
Anastasia, Rivkina, Sergey, Rybalov
openaire   +2 more sources

Innovations in coagulation: improved options for treatment of hemophilia A and B

Thrombosis Research, 2013
The availability of plasma-derived and recombinant coagulation factor products represents an important breakthrough in the management of patients with hemophilia that has led to improvements in life expectancy and quality of life. Current research has focused on enhancing the pharmacokinetic properties of these products.
Ingrid, Pabinger-Fasching, Steven, Pipe
openaire   +2 more sources

Recommendations and potential future options in the treatment of hepatitis B

Expert Opinion on Pharmacotherapy, 2006
The natural history of chronic hepatitis B should be clearly defined before appropriate recommendations for treatment can be advocated. In patients who acquire the disease in early life, the complications of chronic hepatitis B continue to occur as a result of prolonged insidious damage to the liver, even in the low viraemic phase.
Yuen, MF, Lai, CL
openaire   +4 more sources